Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by josameyeron Aug 16, 2010 12:08pm
520 Views
Post# 17353543

RE: RE: Long awaited news coming soon

RE: RE: Long awaited news coming soonUnderground development is progressing, with 410 metres of advance, completed to date. In advance of underground development and mining rehabilitation of the existing ramp, and excavation of a 4.5 metre diameter ventilation raise, were recently completed.Initial mining of ore will be carried out by contractors during the development, with the first ore expected in August 2010. The company plans to mine underground ore, using its own equipment and employees.As development advances, and new equipment arrives, underground production rates are expected to increase to a steady rate of 800 tonnes per day by March 2011. With an expected higher grade +7 grams per tonne average.This will account for 40% of the Black Fox mill designed througput rate. The remaining 60% will be from open pit ore.Further assays are pending from 25 holes. The company plans of adding a third surface drill in Sept 2010. Early in the fourth quarter 2010 the company expects to begin advancing the the 235 m level underground drift at Black Fox to the SE, with this extention of the 235 metre m level drift ,a fourth drill rig will be added.As you can see progress is being made.As always DYODD and good luck to all. Cheers Josa.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse